Cornerstone Planning Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$433K Buy
438
+57
+15% +$57.8K 0.06% 105
2025
Q4
$390K Sell
381
-939
-71% -$898K 0.06% 98
2025
Q3
$1.11M Buy
1,320
+53
+4% +$39.4K 0.18% 57
2025
Q2
$971K Buy
1,267
+835
+193% +$649K 0.2% 35
2025
Q1
$358K Buy
432
+325
+304% +$270K 0.09% 58
2024
Q4
$86.5K Sell
107
-7
-6% -$5.8K 0.02% 121
2024
Q3
$103K Sell
114
-12
-10% -$10.8K 0.03% 110
2024
Q2
$97.7K Buy
126
+38
+43% +$30.4K 0.03% 137
2024
Q1
$64.7K Sell
88
-1
-1% -$712 0.02% 149
2023
Q4
$51.9K Buy
89
+3
+3% +$1.75K 0.02% 180
2023
Q3
$46.2K Buy
86
+15
+21% +$7.73K 0.02% 191
2023
Q2
$33.3K Buy
+71
New +$29.8K 0.01% 323
2022
Q4
$112K Buy
+319
New +$113K 0.05% 146

Other funds holding LLY

Cornerstone Planning Group's LLY Position: Q1 2026 in Review

Cornerstone Planning Group increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $57.8K and bringing the position to 438 shares worth $433K. The position accounts for 0.06% of the portfolio, ranked #105.

Cornerstone Planning Group first reported a position in LLY in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.11M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cornerstone Planning Group held 438 shares of Eli Lilly worth $433K as of Q1 2026.
  • Cornerstone Planning Group bought 57 Eli Lilly shares in Q1 2026, an estimated $57.8K.
  • Eli Lilly made up 0.06% of Cornerstone Planning Group's portfolio in Q1 2026, its #105 holding.
  • Cornerstone Planning Group first reported a position in Eli Lilly in Q4 2022 and has held it in 13 quarters since.
  • Cornerstone Planning Group's Eli Lilly position peaked at $1.11M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.